Stock A397030 APRILBIO CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News AprilBio Co.,Ltd.

Equities

A397030

KR7397030008

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-06-27 pm EDT 		5-day change 1st Jan Change
18,290 KRW -1.14% Intraday chart for AprilBio Co.,Ltd. -6.21% +8.55%
Jun. 24 Evommune, Inc. Secures Exclusive Rights to Develop and Commercialize a Phase 2-Ready IL-18 Targeted Fusion Protein from AprilBio CI
2023 AprilBio Co.,Ltd.(KOSDAQ:A397030) added to S&P Global BMI Index CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Evommune, Inc. Secures Exclusive Rights to Develop and Commercialize a Phase 2-Ready IL-18 Targeted Fusion Protein from AprilBio
CI
AprilBio Co.,Ltd.(KOSDAQ:A397030) added to S&P Global BMI Index
CI
AprilBio Co.,Ltd. announced that it has received KRW 15 billion in funding from Lake Asset Management Ltd., Korea Investment & Securities Co., Ltd., Ehyun Asset Management Co., Ltd.
CI
AprilBio Co.,Ltd. announced that it expects to receive KRW 15 billion in funding from Lake Asset Management Ltd., Korea Investment & Securities Co., Ltd., Ehyun Asset Management Co., Ltd.
CI
AprilBio Co.,Ltd. has completed an IPO in the amount of KRW 20.736 billion.
CI
AprilBio Co.,Ltd. has filed an IPO.
CI
Lundbeck Receives Exclusive Rights to APB-A1, an Innovative Phase I-Ready Bio-Therapeutic for the Treatment of Neuroimmune Diseases from AprilBio
CI
APRILBIO co., Ltd. announced that it has received KRW 10 billion in funding from Yuhan Corporation
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A397030 Stock
  4. News AprilBio Co.,Ltd.